Preclinical evaluation of a novel synthetic antibody for treatment of spontaneously occurring B-cell lymphoma in dogs.

Study Details:

Species: Canines

Tumor: Dogs with Lymphoma/SH-7139

For more information: Click Here or CONTACT DR. MICHELE STEFFEY (530-752-1393) FOR INCLUSION IN THE STUDY.

Purpose of the Study It is possible that treatment with SH 7139 will be an effective therapy for your dog’s lymphoma, and may result in remission.  It is hoped that with the information obtained from this trial, SH 7139 can proceed to clinical trials in people with non-Hodgkin’s lymphoma. The study will enroll adult dogs of any breed with peripheral lymphadenopathy, with confirmed B-cell lymphoma, with a life expectancy of at least 6 weeks. This study intends to recruit both newly diagnosed cases without previous treatment, and relapsed patients that may have failed other treatment options.